Intellective Bio is a biopharmaceutical CDMO committed to accelerating your product development and commercialization. We efficiently use our modern infrastructure and cross-functional experts for R&D to large-scale production volumes from 1 to 210000 liters. Our multiple cGMP manufacturing plants, based in the biotech hub of Suzhou, China are optimized for commercialization in ICH-regulated markets including US, Europe, and China as well as other global territories.

Our regulatory professionals enable our clients to implement registration and commercialization strategies in all major pharmaceutical markets. For product launches in China, we empower clients with our capabilities in production and regulatory affairs to efficiently enter the Chinese market.

With our track record in development and manufacturing of antibodies, ADCs, fusion proteins, and other recombinant proteins, Intellective Bio is your trusted one-stop CDMO partner. Together, let us create infinite possibilities.